Literature DB >> 3707631

An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues.

J Schalkwijk, W B van den Berg, L B van de Putte, L A Joosten.   

Abstract

Hydrogen peroxide is receiving increasing attention as a mediator of tissue damage during inflammation. To evaluate its destructive potential in vivo, we devised a model in which hydrogen peroxide is, initially, the sole mediator of tissue damage. Glucose oxidase, which was made cationic to obtain good retention in tissue, was injected intraarticularly in mouse knee joints. This enzyme produces hydrogen peroxide, using endogenous glucose as a substrate. The local production of hydrogen peroxide induced drastic vascular damage, as measured by 99mTc uptake and leakage of 125I-albumin. The chondrocyte proteoglycan synthesis was severely inhibited, as measured by 35SO4 incorporation. Histologic examination showed impressive inflammatory and degenerative changes, including periarticular infiltration, chondrocyte death, subchondral erosions, and muscle necrosis. Intraarticular administration of catalase could inhibit these vascular effects and cartilage damage. Systemic administration of ebselen, a synthetic glutathione peroxidase-like compound, provided partial protection. Indomethacin and piroxicam were not effective in the acute phase. We think this model is useful both for testing drugs that are purported to act as scavengers of hydrogen peroxide and for studying chronic destructive processes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707631     DOI: 10.1002/art.1780290411

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  The pharmacology of ebselen.

Authors:  M J Parnham; S Leyck; E Graf; E J Dowling; D R Blake
Journal:  Agents Actions       Date:  1991-01

2.  Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase.

Authors:  O I Aruoma; B Halliwell
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

3.  The chondroprotective effects of ferulic acid on hydrogen peroxide-stimulated chondrocytes: inhibition of hydrogen peroxide-induced pro-inflammatory cytokines and metalloproteinase gene expression at the mRNA level.

Authors:  M P Chen; S H Yang; C H Chou; K C Yang; C C Wu; Y H Cheng; Feng-Huei Lin
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

4.  Inflammation-mediated chondrocyte unresponsiveness to insulin-like growth factor-1 is not caused by H2O2.

Authors:  L A Joosten; M M Helsen; W B van den Berg
Journal:  Agents Actions       Date:  1990-01

5.  Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid.

Authors:  H Kaur; S E Edmonds; D R Blake; B Halliwell
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

6.  Short-term immobilization restores and prevents inhibition of chondrocyte synthesis caused by IL-1.

Authors:  P L van Lent; A A van de Loo; L van den Bersselaar; W B van den Berg
Journal:  Agents Actions       Date:  1989-01

7.  Age-related changes in joint damage caused by antigen-induced arthritis in mice.

Authors:  H M van Beuningen; W B van den Berg; J Schalkwijk; O J Arntz; L B van de Putte
Journal:  Agents Actions       Date:  1988-02

Review 8.  Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis.

Authors:  Neide Tomimura Costa; Tatiana Mayumi Veiga Iriyoda; Daniela Frizon Alfieri; Andréa Name Colado Simão; Isaias Dichi
Journal:  Inflammopharmacology       Date:  2018-07-30       Impact factor: 4.473

9.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

10.  A peroxide-induced inflammation model for drug testing.

Authors:  C R Spillert; M A Pelosi; L P Parmer; E J Lazaro
Journal:  Agents Actions       Date:  1987-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.